Tue, Aug 4, 2015
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Despite negative performance in May hedge funds offer top risk/reward profile across asset classes

Wednesday, June 23, 2010

From Kirsten Bischoff, Opalesque New York:

Hedge funds' defensive positioning may have opened the industry to criticism as performance slightly lags equities indices during bull runs, but it has also helped snare the favor (and assets) of large financial institutions.

Hedge funds, which financial firm SEB expects will track slightly lower than equities in 2010, presents the strongest risk/return profile of all asset classes. "We predict that 2010 will be a somewhat better year for hedge funds than a normal year," says the firm, which is focusing most of their hedge fund investments in equity l/s, global macro and multi-strat managers (with a watchful eye on the event driven space, which they also expect to do well). ("The Debt Burden: Can the World Handle the Pressure?" May 2010)

After a period of time extending through 2009, where many investors shied away from the more complex strategies, firms like SEB and HSBC (which likes discretionary macro, distressed and event driven) are leading the way back into more robust portfolios that have exposures to all asset classes. Opalesque heard this position echoed in the recent Miami Roundtable when Rainford Knight, PhD and Managing Partner of the Florida Institute of Finance commented "Looking at the data we can identify a shift away from long/shor......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Activist News - Celgene says patent-fighting hedge fund manager wants to short its shares[more]

    From Reuters.com: Celgene Corp, one of the world's largest biotechnology companies, has accused U.S. hedge fund manager Kyle Bass of attempting to profit from his attempts to wipe out several major drug patents through his Coalition for Affordable Drugs. The company asked the U.S. Patent and T

  2. Einhorn's Greenlight Capital hedge fund slumps 6.1 percent in July[more]

    From Reuters/Thefiscaltimes.com: Hedge fund mogul David Einhorn's Greenlight Capital slumped 6.1 percent in July and is now down 9 percent for the year after gold, one of the fund's top holdings, tumbled to five-year lows last week. Greenlight notified clients of its returns late on Friday, ac

  3. Performance - Some hedge fund small-cap energy stocks have been free falling, Dan Loeb's simple strategy destroys the market, Baupost lost 1.4% last quarter as energy bargains proved elusive[more]

    Some hedge fund small-cap energy stocks have been free falling From Marketrealist.com: According to a July 28, 2015, Bloomberg article, there was a 34% fall in small-cap energy stocks over the past three months. These shares are tracked by the Russell 2000 Energy Index. Small-cap energy

  4. Legal - Hedge funds hit Rothstein Kass with $75m malpractice suit, JPMorgan questioned on private bank’s hedge fund disclosures, Kijani fund, seized by regulators in Cayman Islands, spotlights risks in lightly regulated market[more]

    Hedge funds hit Rothstein Kass with $75m malpractice suit From Law360.com: Two investment funds have sued Rothstein Kass & Co. PC for at least $75 million, claiming the New Jersey auditing firm committed accounting malpractice by failing to properly scrutinize overblown valuations of the

  5. Assets - Hedge funds are getting smoked by the commodities slump, Global ETF assets could more than double by 2020[more]

    Hedge funds are getting smoked by the commodities slump From Businessinsider.in: The collapse in commodity prices has burnt another hedge fund. Vermillion, a commodity hedge fund backed by Carlyle Group, has seen its flagship fund's assets fall from nearly $2 billion to less $50 million,

 

banner